0001375151-18-000065.txt : 20180810 0001375151-18-000065.hdr.sgml : 20180810 20180810160622 ACCESSION NUMBER: 0001375151-18-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180808 FILED AS OF DATE: 20180810 DATE AS OF CHANGE: 20180810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farfel Gail M CENTRAL INDEX KEY: 0001614780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 181008892 MAIL ADDRESS: STREET 1: 142 TEMPLE STREET STREET 2: SUITE 205 CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_153393156441280.xml FORM 4 X0306 4 2018-08-08 0 0001375151 ZOGENIX, INC. ZGNX 0001614780 Farfel Gail M C/O ZOGENIX, INC. 5858 HORTON STREET, SUITE 455 EMERYVILLE CA 94608 0 1 0 0 EVP/Chief Development Officer Common Stock 2018-08-08 4 M 0 7000 13.96 A 14143 D Common Stock 2018-08-08 4 S 0 5100 52.4152 D 9043 D Common Stock 2018-08-08 4 S 0 1900 53.1553 D 7143 D Stock Option (Right to Buy) 13.96 2018-08-08 4 M 0 7000 0 D 2025-06-30 Common Stock 7000.0 44250 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $51.95 to $52.90, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $52.95 to $53.53, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option was granted on July 1, 2015, which is the vesting commencement date. One-fourth of the shares subject to the option will vest on the first anniversary of the vesting commencement date, and the remaining shares subject to the option shall vest in thirty-six equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment with the Company on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Gail Farfel 2018-08-10